Barbara Dalton

Barbara Dalton

Corporate Officer/Principal chez PFIZER INC.
71 ans
Health Technology
Finance
Commercial Services

Profil

Barbara J.
Dalton
currently works at Terragen Discovery, Inc., as Director, Second Genome, Inc., as Director, Cydan LLC, as Director, Ixchelsis Ltd., as Director, Penn State Research Foundation, as Director, Advanced MR Analytics AB, as Director, Petra Pharma Corp., as Director, Priovant Therapeutics, Inc., as Director, Alzheimer's Disease Research Foundation, as Director, Pfizer Inc., as Vice President-Worldwide Business Development from 2007, Pfizer Venture Investments LLC, as Vice President & Senior Managing Partner from 2012, and The New York City Investment Fund Manager, Inc., as Advisor.
Dr. Dalton also formerly worked at Scimagix, Inc., as Chairman, Aspira Women's Health, Inc., as Director, Celladon Corp., as Independent Director in 2014, Complexa, Inc., as Director, Artios Pharma Ltd., as Director, Ijetset Corp., as Director, Physiome Sciences, Inc., as Director, Gryphon Therapeutics, Inc., as Director, Melinta Subsidiary Corp., as Director, National Venture Capital Association, as Director, New York Biotechnology Association, Inc., as Director, Ablexis LLC, as Director, Cydan II, Inc., as Director, Vtesse, Inc., as Director, Lodo Therapeutics Corp., as Director, Imara, Inc., as Independent Director, Morphic Holding, Inc., as Director, Tiburio Therapeutics, Inc., as Director, GSK Equity Investments Ltd, as President from 1993 to 2003, EuclidSR Partners, as Partner from 2005 to 2007, and SR One Capital Management LP, as President from 1993 to 2003.
Dr. Dalton received her doctorate degree in 1983 from Drexel University College of Medicine and undergraduate degree from Eberly College of Science.

Postes actifs de Barbara Dalton

SociétésPosteDébut
PFIZER INC. Corporate Officer/Principal 01/01/2007
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Consultant / Advisor -
Directeur/Membre du Conseil -
Private Equity Investor 01/09/2007
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Anciens postes connus de Barbara Dalton

SociétésPosteFin
░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Barbara Dalton

Formation de Barbara Dalton

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

68

Relations au 1er degré

35

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées35

Health Technology

Health Technology

Health Technology

Finance

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

Finance

Health Technology

Finance

Finance

Commercial Services

Commercial Services

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Distribution Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Miscellaneous

  1. Bourse
  2. Insiders
  3. Barbara Dalton
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT